Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 67, Issue 10
Volume 67, Issue 10
15 November 2018
ISSN 1058-4838
EISSN 1537-6591

Volume 67, Issue 10, 15 November 2018

NEWS

Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages i–iii, https://doi.org/10.1093/cid/ciy730

IN THE LITERATURE

Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages iii–iv, https://doi.org/10.1093/cid/ciy831

IDSA FEATURES

AASLD-IDSA HCV Guidance Panel
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1477–1492, https://doi.org/10.1093/cid/ciy585

COMMENTARY

Ravi Jhaveri and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1493–1497, https://doi.org/10.1093/cid/ciy586

Currently, risk-based hepatitis C virus (HCV) screening is recommended for women of childbearing age and pregnant women despite a high HCV prevalence. For many reasons outlined here, the time has come for universal screening for HCV for all pregnant women.

ARTICLES AND COMMENTARIES

John M McLaughlin and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1498–1506, https://doi.org/10.1093/cid/ciy312

Our study demonstrated real-world, direct effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia following introduction into a routine immunization program among adults aged ≥65 years, many of whom had immunocompromising and chronic medical conditions.

S M Iftekhar Uddin and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1507–1514, https://doi.org/10.1093/cid/ciy317

Human coronaviruses (HCoVs) are associated with respiratory illnesses in infants aged 0–6 months in a rural South Asian setting. HCoV incidence increases beyond the first month of life. Four tested species (229E, OC43, NL63, HKU1) were present.

Audrie Lin and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1515–1522, https://doi.org/10.1093/cid/ciy320

The trial found that individual handwashing and sanitation interventions significantly reduced childhood Giardia infections. Combined interventions provided no additional benefit. To reduce Giardia infection, individual interventions may be more feasible and cost-effective than combined interventions in similar rural, low-income settings.

Martina Kosikova and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1523–1532, https://doi.org/10.1093/cid/ciy327

Influenza antibodies from hosts with preexisting immunity showed broader cross-reactivity than those without preexisting immunity. Repeated influenza exposures imprinted both antibody quantity and antibody quality. To improve vaccine effectiveness, vaccine strain selection needs to consider the preexisting immunity in humans.

John Treanor
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1533–1534, https://doi.org/10.1093/cid/ciy330
Monica E Patton and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1535–1542, https://doi.org/10.1093/cid/ciy318

Herpes simplex virus type 1/2 (HSV-1/2) seroprevalence was stable among pregnant women between 1999–2006 and 2007–2014. HSV-1/-2 seronegativity increased among those with ≤3 sex partners highlighting vulnerability to primary HSV infection and increased risk of neonatal herpes.

Cindy S Chu and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1543–1549, https://doi.org/10.1093/cid/ciy319

Vivax malaria relapses frequently even in low-transmission settings. Chloroquine delays but does not prevent recurrences. Adding primaquine to a slowly eliminated schizonticide significantly reduces recurrences and improves hematocrit, but this advantage is offset by hemolysis in G6PD-deficient females.

Timothy C Jenkins and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1550–1558, https://doi.org/10.1093/cid/ciy268

Twenty-six hospitals participated in a statewide collaborative to improve the diagnosis and treatment of inpatient urinary tract and skin infections. Overall performance targets for the collaborative were partially met; however, a number of hospitals achieved substantial changes in prescribing.

Patrick K Munywoki and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1559–1567, https://doi.org/10.1093/cid/ciy313

This is the first household study of multiple respiratory viruses in a low-income setting that used intensive sampling regardless of symptoms. There was a remarkably high frequency of virus infection and illness, demonstrating the opportunity for complex interactions.

Kellie J Goodlet and Kathleen A Fairman
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1568–1574, https://doi.org/10.1093/cid/ciy329

In a retrospective cohort analysis of claims data, patients receiving antibiotic/immunomodulatory pharmacotherapy for post–Lyme disease syndrome (PLDS) had greater 90-day incidence of all-cause hospitalizations, all-cause emergency department visits, infections, and electrolyte abnormalities, compared with PLDS patients not receiving such therapies.

Jon C Mills and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1575–1581, https://doi.org/10.1093/cid/ciy264

We observed a dose–response relationship between the cumulative burden of depression and all-cause mortality among women living with human immunodeficiency virus (HIV). Shortening the duration of depressive episodes through enhanced treatment protocols in HIV primary care settings may interrupt accumulation of mortality risk.

Alice E Barsoumian and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1582–1587, https://doi.org/10.1093/cid/ciy322

Similar factors affect career choice among military internal medicine residents and their civilian counterparts, including mentorship, learning style, and salary. Recruitment strategies for infectious (ID) diseases physicians should focus on residency opportunities, considering reasons for continued interest in military ID.

Selly Ba and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1588–1594, https://doi.org/10.1093/cid/ciy324

Our trial of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate in antiretroviral therapy–naive HIV-2–infected individuals for 48 weeks, in a resource-limited setting, demonstrated favorable immunovirologic outcomes and was well tolerated.

Yu-Lin Lee and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1595–1602, https://doi.org/10.1093/cid/ciy328

During an AHA outbreak, we found that HIV-infected patients had a lower severity, but delayed resolution, of AHA than HIV-uninfected patients. Better viral suppression by cART alleviated the impact of HIV infection on the disease course of AHA in HIV-infected patients.

Kee Thai Yeo and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1603–1609, https://doi.org/10.1093/cid/ciy311

This study describes the burden of respiratory virus infections (RVIs) among preterm infants in the tropics. RVIs affected >1 of 10 infants born at ≤32 weeks’ gestation before age 2 years, with respiratory syncytial virus being the main causative pathogen.

BRIEF REPORTS

Caitlin R Rausch and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1610–1613, https://doi.org/10.1093/cid/ciy406
Rachel M Burke and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1614–1616, https://doi.org/10.1093/cid/ciy424
Matthew M Ippolito and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1617–1620, https://doi.org/10.1093/cid/ciy405

Plasma concentrations of chloroquine and desethyl-chloroquine did not differ among individuals receiving protease inhibitor-based antiretroviral therapy (ART) (n = 9), efavirenz-based ART (n = 15), other ART (n = 8), or no ART (n = 31). Efavirenz appeared to inhibit chloroquine desethylation.

INVITED ARTICLE

IMMUNOCOMPROMISED HOSTS

Michail S Lionakis and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1621–1630, https://doi.org/10.1093/cid/ciy473

Despite the effectiveness of mold-active prophylaxis, breakthrough invasive mold infections (bIMIs) are encountered in high risk hematology patients. This viewpoint outlines different clinical scenarios and presents the diagnostic and treatment challenges of bIMIs in that patient population.

PHOTO QUIZ

Ayana Morales and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1631–1634, https://doi.org/10.1093/cid/ciy270

CORRESPONDENCE

Jeff Hosry and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1635–1636, https://doi.org/10.1093/cid/ciy387
Elizabeth Dodds Ashley and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page 1637, https://doi.org/10.1093/cid/ciy392
David J Epstein and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Pages 1637–1639, https://doi.org/10.1093/cid/ciy397
Deirdre A Collins and Thomas V Riley
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page 1639, https://doi.org/10.1093/cid/ciy249
L Clifford McDonald and others
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page 1640, https://doi.org/10.1093/cid/ciy251

ERRATA

Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page 1641, https://doi.org/10.1093/cid/ciy569
Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page 1641, https://doi.org/10.1093/cid/ciy734

COVER

Clinical Infectious Diseases, Volume 67, Issue 10, 15 November 2018, Page NP, https://doi.org/10.1093/cid/ciy855
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close